nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—CYP2C19—Rosuvastatin—atherosclerosis	0.114	0.121	CbGbCtD
Quazepam—CYP2C19—Simvastatin—atherosclerosis	0.106	0.113	CbGbCtD
Quazepam—CYP2C19—Lovastatin—atherosclerosis	0.104	0.11	CbGbCtD
Quazepam—CYP2C9—Rosuvastatin—atherosclerosis	0.0947	0.101	CbGbCtD
Quazepam—CYP2C9—Simvastatin—atherosclerosis	0.088	0.0937	CbGbCtD
Quazepam—CYP2C9—Pravastatin—atherosclerosis	0.0862	0.0917	CbGbCtD
Quazepam—CYP2C9—Lovastatin—atherosclerosis	0.0862	0.0917	CbGbCtD
Quazepam—CYP3A4—Rosuvastatin—atherosclerosis	0.0551	0.0586	CbGbCtD
Quazepam—CYP3A4—Ezetimibe—atherosclerosis	0.0551	0.0586	CbGbCtD
Quazepam—CYP3A4—Simvastatin—atherosclerosis	0.0512	0.0545	CbGbCtD
Quazepam—CYP3A4—Lovastatin—atherosclerosis	0.0501	0.0533	CbGbCtD
Quazepam—CYP3A4—Pravastatin—atherosclerosis	0.0501	0.0533	CbGbCtD
Quazepam—GABRG3—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.24e-05	0.000873	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	5.22e-05	0.00087	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.21e-05	0.000868	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.16e-05	0.00086	CbGpPWpGaD
Quazepam—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	5.15e-05	0.000858	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.12e-05	0.000853	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.09e-05	0.000848	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—APOB—atherosclerosis	5.08e-05	0.000847	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	5.03e-05	0.000839	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	5.03e-05	0.000839	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.99e-05	0.000832	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—APOB—atherosclerosis	4.99e-05	0.000832	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.96e-05	0.000826	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	4.94e-05	0.000824	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.92e-05	0.00082	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.92e-05	0.000819	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.9e-05	0.000817	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—APOB—atherosclerosis	4.87e-05	0.000812	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	4.85e-05	0.000809	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.84e-05	0.000807	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.78e-05	0.000797	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ALB—atherosclerosis	4.73e-05	0.000788	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.73e-05	0.000788	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.67e-05	0.000778	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.67e-05	0.000778	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.67e-05	0.000778	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.67e-05	0.000778	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.61e-05	0.000768	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—TNF—atherosclerosis	4.58e-05	0.000764	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	4.49e-05	0.000748	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.45e-05	0.000742	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.36e-05	0.000727	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.29e-05	0.000714	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.27e-05	0.000711	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	4.25e-05	0.000709	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	4.25e-05	0.000709	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	4.25e-05	0.000709	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	4.25e-05	0.000709	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—AKT1—atherosclerosis	4.24e-05	0.000706	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.21e-05	0.000701	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	4.2e-05	0.0007	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.18e-05	0.000697	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.14e-05	0.000689	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.11e-05	0.000685	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.11e-05	0.000685	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LDLRAP1—atherosclerosis	4.06e-05	0.000676	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	4.06e-05	0.000676	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.03e-05	0.000672	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.02e-05	0.00067	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.97e-05	0.000661	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.95e-05	0.000658	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ALB—atherosclerosis	3.89e-05	0.000649	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	3.89e-05	0.000648	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.88e-05	0.000647	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.85e-05	0.000642	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ALB—atherosclerosis	3.84e-05	0.000639	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLTP—atherosclerosis	3.82e-05	0.000636	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.78e-05	0.000631	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	3.75e-05	0.000624	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	3.7e-05	0.000617	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—IL6—atherosclerosis	3.7e-05	0.000617	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	3.62e-05	0.000603	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.54e-05	0.000589	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.53e-05	0.000588	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.51e-05	0.000586	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.49e-05	0.000582	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLTP—atherosclerosis	3.48e-05	0.00058	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.44e-05	0.000574	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.41e-05	0.000569	CbGpPWpGaD
Quazepam—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.39e-05	0.000566	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LTA4H—atherosclerosis	3.31e-05	0.000551	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG8—atherosclerosis	3.31e-05	0.000551	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.31e-05	0.000551	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.27e-05	0.000544	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.22e-05	0.000537	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.2e-05	0.000534	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ALB—atherosclerosis	3.18e-05	0.000531	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.18e-05	0.000531	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ALB—atherosclerosis	3.13e-05	0.000521	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.11e-05	0.000518	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.08e-05	0.000514	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.07e-05	0.000512	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ALB—atherosclerosis	3.05e-05	0.000509	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LTA4H—atherosclerosis	3.02e-05	0.000503	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG8—atherosclerosis	3.02e-05	0.000503	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ALB—atherosclerosis	3e-05	0.0005	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.98e-05	0.000496	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.81e-05	0.000469	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.75e-05	0.000458	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.62e-05	0.000437	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG1—atherosclerosis	2.62e-05	0.000436	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.51e-05	0.000418	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—FABP4—atherosclerosis	2.46e-05	0.00041	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LCAT—atherosclerosis	2.46e-05	0.00041	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.44e-05	0.000407	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOA4—atherosclerosis	2.41e-05	0.000402	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.38e-05	0.000397	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP7A1—atherosclerosis	2.37e-05	0.000395	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLTP—atherosclerosis	2.29e-05	0.000382	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.26e-05	0.000377	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LCAT—atherosclerosis	2.24e-05	0.000374	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—FABP4—atherosclerosis	2.24e-05	0.000374	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOA4—atherosclerosis	2.2e-05	0.000367	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CYP27A1—atherosclerosis	2.19e-05	0.000365	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.16e-05	0.00036	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.16e-05	0.00036	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.11e-05	0.000351	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALOX15—atherosclerosis	2.08e-05	0.000346	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	2.08e-05	0.000346	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOA2—atherosclerosis	2.08e-05	0.000346	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	2.08e-05	0.000346	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.06e-05	0.000343	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCG5—atherosclerosis	2.05e-05	0.000342	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.05e-05	0.000342	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2e-05	0.000333	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.99e-05	0.000332	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.99e-05	0.000332	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LPA—atherosclerosis	1.98e-05	0.00033	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.97e-05	0.000328	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—BGN—atherosclerosis	1.92e-05	0.00032	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.92e-05	0.00032	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.91e-05	0.000318	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOA5—atherosclerosis	1.9e-05	0.000317	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.89e-05	0.000316	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOA2—atherosclerosis	1.89e-05	0.000316	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.89e-05	0.000316	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.89e-05	0.000316	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.87e-05	0.000312	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.87e-05	0.000312	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.85e-05	0.000308	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.83e-05	0.000305	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.81e-05	0.000301	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LPA—atherosclerosis	1.81e-05	0.000301	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.79e-05	0.000299	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.79e-05	0.000298	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.77e-05	0.000294	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—BGN—atherosclerosis	1.75e-05	0.000292	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.74e-05	0.00029	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOA5—atherosclerosis	1.73e-05	0.000289	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.68e-05	0.000281	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.67e-05	0.000278	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.65e-05	0.000275	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.63e-05	0.000272	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.63e-05	0.000272	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.63e-05	0.000272	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.61e-05	0.000268	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.58e-05	0.000264	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.58e-05	0.000263	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LIPC—atherosclerosis	1.57e-05	0.000262	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.57e-05	0.000262	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOC3—atherosclerosis	1.56e-05	0.000261	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LDLR—atherosclerosis	1.56e-05	0.000259	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CETP—atherosclerosis	1.52e-05	0.000253	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.49e-05	0.000248	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—FABP4—atherosclerosis	1.48e-05	0.000246	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LCAT—atherosclerosis	1.48e-05	0.000246	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.45e-05	0.000242	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOA4—atherosclerosis	1.45e-05	0.000242	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.44e-05	0.000241	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.44e-05	0.000239	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LIPC—atherosclerosis	1.44e-05	0.000239	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOC3—atherosclerosis	1.43e-05	0.000238	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.43e-05	0.000238	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LDLR—atherosclerosis	1.42e-05	0.000236	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.42e-05	0.000236	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CETP—atherosclerosis	1.39e-05	0.000231	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.37e-05	0.000229	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.33e-05	0.000221	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.32e-05	0.00022	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.29e-05	0.000215	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.25e-05	0.000209	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOA2—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.25e-05	0.000208	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.24e-05	0.000207	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.23e-05	0.000206	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.22e-05	0.000204	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LPA—atherosclerosis	1.19e-05	0.000199	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—BGN—atherosclerosis	1.15e-05	0.000192	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOA5—atherosclerosis	1.14e-05	0.00019	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.13e-05	0.000188	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.12e-05	0.000186	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.1e-05	0.000183	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.06e-05	0.000177	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.05e-05	0.000175	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOB—atherosclerosis	1.01e-05	0.000168	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.79e-06	0.000163	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—LPL—atherosclerosis	9.61e-06	0.00016	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—HMOX1—atherosclerosis	9.58e-06	0.00016	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.53e-06	0.000159	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LIPC—atherosclerosis	9.47e-06	0.000158	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOC3—atherosclerosis	9.41e-06	0.000157	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GPX1—atherosclerosis	9.37e-06	0.000156	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LDLR—atherosclerosis	9.35e-06	0.000156	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOB—atherosclerosis	9.18e-06	0.000153	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CETP—atherosclerosis	9.14e-06	0.000152	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CD36—atherosclerosis	9.13e-06	0.000152	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GSTM1—atherosclerosis	8.93e-06	0.000149	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—LPL—atherosclerosis	8.76e-06	0.000146	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.75e-06	0.000146	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.65e-06	0.000144	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GPX1—atherosclerosis	8.55e-06	0.000142	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PPARA—atherosclerosis	8.49e-06	0.000141	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CD36—atherosclerosis	8.32e-06	0.000139	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.26e-06	0.000138	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AGT—atherosclerosis	8.22e-06	0.000137	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOE—atherosclerosis	8.05e-06	0.000134	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—CAV1—atherosclerosis	7.98e-06	0.000133	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—APOA1—atherosclerosis	7.96e-06	0.000133	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MTHFR—atherosclerosis	7.89e-06	0.000131	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PPARA—atherosclerosis	7.74e-06	0.000129	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AGT—atherosclerosis	7.5e-06	0.000125	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.36e-06	0.000123	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOE—atherosclerosis	7.34e-06	0.000122	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—CAV1—atherosclerosis	7.28e-06	0.000121	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.27e-06	0.000121	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—APOA1—atherosclerosis	7.26e-06	0.000121	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PPARG—atherosclerosis	7.02e-06	0.000117	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—INS—atherosclerosis	6.88e-06	0.000115	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PIK3CG—atherosclerosis	6.63e-06	0.00011	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PPARG—atherosclerosis	6.4e-06	0.000107	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.32e-06	0.000105	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ALB—atherosclerosis	6.31e-06	0.000105	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—INS—atherosclerosis	6.27e-06	0.000105	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOB—atherosclerosis	6.05e-06	0.000101	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—NOS3—atherosclerosis	6.03e-06	0.000101	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.89e-06	9.81e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—LPL—atherosclerosis	5.78e-06	9.63e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ALB—atherosclerosis	5.75e-06	9.59e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GPX1—atherosclerosis	5.64e-06	9.4e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.52e-06	9.2e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—NOS3—atherosclerosis	5.5e-06	9.17e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CD36—atherosclerosis	5.49e-06	9.15e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.2e-06	8.67e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PPARA—atherosclerosis	5.1e-06	8.51e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS2—atherosclerosis	5.03e-06	8.39e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AGT—atherosclerosis	4.94e-06	8.24e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOE—atherosclerosis	4.84e-06	8.07e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—CAV1—atherosclerosis	4.8e-06	8e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—APOA1—atherosclerosis	4.79e-06	7.98e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.37e-06	7.29e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PPARG—atherosclerosis	4.22e-06	7.03e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—INS—atherosclerosis	4.14e-06	6.9e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ALB—atherosclerosis	3.79e-06	6.32e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—NOS3—atherosclerosis	3.63e-06	6.05e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.32e-06	5.53e-05	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—AKT1—atherosclerosis	2.77e-06	4.62e-05	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—AKT1—atherosclerosis	2.53e-06	4.22e-05	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—AKT1—atherosclerosis	1.67e-06	2.78e-05	CbGpPWpGaD
